Literature DB >> 14745076

PEN2 is not a genetic risk factor for Alzheimer's disease in a large family sample.

L Bertram1, R Menon, K Mullin, M Parkinson, M L Bradley, D Blacker, R E Tanzi.   

Abstract

PEN2 is a reasonable Alzheimer's disease (AD) candidate gene because it is a necessary component of the gamma-secretase complex that generates beta-amyloid peptide. Moreover, its gene (PEN2) maps to a highly significant linkage region on chromosome 19q13. Four common polymorphisms in PEN2 were tested for genetic association with AD in a large and carefully ascertained AD family sample (789 subjects from 202 nuclear families) using single-locus and haplotype-based analyses. These results do not suggest PEN2 to be a major AD risk factor.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14745076     DOI: 10.1212/01.wnl.0000103283.65914.0b

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  2 in total

1.  PEN-2 gene mutation in a familial Alzheimer's disease case.

Authors:  C Sala Frigerio; P Piscopo; E Calabrese; A Crestini; L Malvezzi Campeggi; R Civita di Fava; S Fogliarino; D Albani; G Marcon; R Cherchi; R Piras; G Forloni; A Confaloni
Journal:  J Neurol       Date:  2005-03-16       Impact factor: 4.849

Review 2.  Actions of Metformin in the Brain: A New Perspective of Metformin Treatments in Related Neurological Disorders.

Authors:  Nuojin Li; Tian Zhou; Erkang Fei
Journal:  Int J Mol Sci       Date:  2022-07-27       Impact factor: 6.208

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.